Federal and Regulatory Outreach
Response to Advance Notice for Medicare Advantage Plan Year 2023
March 8, 2022
Medicare Advantage Prior Authorization Regulatory
AMRPA Joint Letter to HHS Sec. Becerra on LTACHs and IRFs
January 5, 2022
COVID-19 Medicare Advantage Prior Authorization Regulatory
AMRPA Statement on Senate Reintroduction of Improving Seniors’ Timely Access to Care Act
October 21, 2021
Legislative Medicare Advantage Prior Authorization
AMRPA Letter of Support for Prior Authorization Reform Bill H.R. 3173
May 14, 2021
Legislative Medicare Advantage Prior Authorization
AMRPA & NALTH Send Joint Response to CMS on Medicare Advantage Prior Authorization Issues during the Public Health Emergency
March 18, 2021
Medicare Advantage Prior Authorization Regulatory
AMRPA Responds to MedPAC December 2020 Session on IRF Payment Adequacy and Access
December 29, 2020
Medicare Advantage MedPAC Regulatory
AMRPA Submits Policy Priorities & Recommendations to Biden-Harris Transition Team
December 18, 2020
COVID-19 IMPACT Act Legislative Medicare Advantage Price Transparency Prior Authorization Telehealth
AMRPA & NALTH Send Joint Letter to CMS on Medicare Advantage Prior Authorization
December 9, 2020
Medicare Advantage Prior Authorization Regulatory
AMRPA Submits Comment to CMS on CY 2022 Medicare Advantage and Part D Advance Notice Parts I and II
November 30, 2020
Medicare Advantage Prior Authorization Regulatory
AMRPA Response to Medicare Advantage Part C Proposed Rule for FY 2021 and 2022
April 6, 2020
Medicare Advantage Prior Authorization
AMRPA Responds to CMS: Advance Notice of Methodological Changes for Calendar Year (CY) 2021 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies – Part II
March 6, 2020
Medicare Advantage Prior Authorization Regulatory
Response to CMS Request for Information on Prior Authorization